FENOFIBRATE vs PITAVASTATIN

Compare FENOFIBRATE (Fenofibrate) and PITAVASTATIN (Pitavastatin Calcium) — clinical data, side effects, and patient experiences.

FENOFIBRATE

Fenofibrate, Tricor, Fenoglide · Fibrate

How it works

12.1 Mechanism of Action The active moiety of fenofibrate is fenofibric acid. The pharmacological effects of fenofibric acid in both animals and humans have been extensively studie...

Approved for

1 INDICATIONS AND USAGE Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C

Total-C

TG and Apo B

total cholesterol (Total-C)

OralTablet

PITAVASTATIN

Pitavastatin Calcium · Other

How it works

12.1 Mechanism of Action Pitavastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonat...

Approved for

See full prescribing information

OralTablet

Quick Comparison

FENOFIBRATEPITAVASTATIN

Drug Class

Fibrate

Other

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

FENOFIBRATE

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

PITAVASTATIN

Muscle Pain

>10%

Diarrhea

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

FDA Warnings

FENOFIBRATE

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate
Risks are increased during co-administration with a statin (with a significantly higher rate observed for gemfibrozil), particularly in elderly patients and patients with diabetes, renal failure, or hypothyroidism ( 5
Cholelithiasis: Fenofibrate increases cholesterol excretion into the bile, leading to risk of cholelithiasis
The Action to Control Cardiovascular Risk in Diabetes Lipid (ACCORD Lipid) trial was a randomized placebo-controlled study of 5518 patients with type 2 diabetes mellitus on background statin therapy treated with fenofibrate

PITAVASTATIN

5 WARNINGS AND PRECAUTIONS • Myopathy and Rhabdomyolysis: Risk factors include age 65 or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher pitavastatin tablets dosage
Temporarily discontinue pitavastatin tablets in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis
Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing the pitavastatin tablets dosage
Rare reports of fatal and non-fatal hepatic failure have occurred

Community Sentiment Analysis

Based on 5 Reddit discussions

FENOFIBRATE

positive

5 threads

PITAVASTATIN

positive

0 threads

Community Discussions

5 Reddit threads analysed for FENOFIBRATE

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

17 upvotes

Patient Experiences (r/pharmacy, r/AskDocs & more)

Why are there so many different strengths of fenofibrate?

Tablets: 40, 48, 54, 120, 145, & 160mg Capsules: 43, 50, 67, 130, 134, 150, & 200mg Micronized caps: 30 & 90mg

r/pharmacy66223y ago

Mishearing a Drug Name

Was reviewing a patient's medical chart. Thought to myself "Man I wonder if anyone mixed up Fenofibrate and Phenobarb". Any times when you or someone you know mixed up two sound alike drugs?

r/pharmacy10101y ago

Fenofibrate v.s. Feno-Super v.s. Feno-Micro

Besides the different doses offered with each formulation, does anyone know the difference between these three forms of fenofibrate? They're not interchangeable with each other either.

r/pharmacy659y ago

Fenofibrate and Zetia

Has anyone seen this combination used in the retail setting? The Zetia package insert states these can be used in combination, but I was just wondering how that translates to real life.

r/pharmacy3912y ago

How to use FDA orange book?

I know we can use FDA orange book to find an approved generic substitution for certain meds with different release mechanism like diltiazem, fenofibrate. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf I am been looking at the orange book and still not sure what is the b

r/pharmacy2410y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for PITAVASTATIN yet.

FENOFIBRATE vs PITAVASTATIN: What You Should Know

Key Differences

FENOFIBRATE is a Fibrate, while PITAVASTATIN belongs to the Other class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

FENOFIBRATE carries 4 FDA warnings. PITAVASTATIN carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

FENOFIBRATE vs GEMFIBROZIL→Atorvastatin vs PITAVASTATIN→Atorvastatin vs FENOFIBRATE→PITAVASTATIN vs Rosuvastatin→FENOFIBRATE vs Rosuvastatin→PITAVASTATIN vs SIMVASTATIN→

Loading comparison data...

FENOFIBRATE vs PITAVASTATIN

Compare FENOFIBRATE (Fenofibrate) and PITAVASTATIN (Pitavastatin Calcium) — clinical data, side effects, and patient experiences.

FENOFIBRATE

Fenofibrate, Tricor, Fenoglide · Fibrate

How it works

12.1 Mechanism of Action The active moiety of fenofibrate is fenofibric acid. The pharmacological effects of fenofibric acid in both animals and humans have been extensively studie...

Approved for

1 INDICATIONS AND USAGE Fenofibrate tablet USP is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: To reduce elevated LDL-C

Total-C

TG and Apo B

total cholesterol (Total-C)

OralTablet

PITAVASTATIN

Pitavastatin Calcium · Other

How it works

12.1 Mechanism of Action Pitavastatin is an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonat...

Approved for

See full prescribing information

OralTablet

Quick Comparison

FENOFIBRATEPITAVASTATIN

Drug Class

Fibrate

Other

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

FENOFIBRATE

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

PITAVASTATIN

Muscle Pain

>10%

Diarrhea

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Joint Pain

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

FDA Warnings

FENOFIBRATE

5 WARNINGS AND PRECAUTIONS Hepatotoxicity : Serious drug-induced liver injury, including liver transplantation and death, has been reported with fenofibrate
Risks are increased during co-administration with a statin (with a significantly higher rate observed for gemfibrozil), particularly in elderly patients and patients with diabetes, renal failure, or hypothyroidism ( 5
Cholelithiasis: Fenofibrate increases cholesterol excretion into the bile, leading to risk of cholelithiasis
The Action to Control Cardiovascular Risk in Diabetes Lipid (ACCORD Lipid) trial was a randomized placebo-controlled study of 5518 patients with type 2 diabetes mellitus on background statin therapy treated with fenofibrate

PITAVASTATIN

5 WARNINGS AND PRECAUTIONS • Myopathy and Rhabdomyolysis: Risk factors include age 65 or greater, uncontrolled hypothyroidism, renal impairment, concomitant use with certain other drugs, and higher pitavastatin tablets dosage
Temporarily discontinue pitavastatin tablets in patients experiencing an acute or serious condition at high risk of developing renal failure secondary to rhabdomyolysis
Inform patients of the risk of myopathy and rhabdomyolysis when starting or increasing the pitavastatin tablets dosage
Rare reports of fatal and non-fatal hepatic failure have occurred

Community Sentiment Analysis

Based on 5 Reddit discussions

FENOFIBRATE

positive

5 threads

PITAVASTATIN

positive

0 threads

Community Discussions

5 Reddit threads analysed for FENOFIBRATE

Overall Sentiment

Mixed

Comparison Threads

Avg Post Score

17 upvotes

Patient Experiences (r/pharmacy, r/AskDocs & more)

Why are there so many different strengths of fenofibrate?

Tablets: 40, 48, 54, 120, 145, & 160mg Capsules: 43, 50, 67, 130, 134, 150, & 200mg Micronized caps: 30 & 90mg

r/pharmacy66223y ago

Mishearing a Drug Name

Was reviewing a patient's medical chart. Thought to myself "Man I wonder if anyone mixed up Fenofibrate and Phenobarb". Any times when you or someone you know mixed up two sound alike drugs?

r/pharmacy10101y ago

Fenofibrate v.s. Feno-Super v.s. Feno-Micro

Besides the different doses offered with each formulation, does anyone know the difference between these three forms of fenofibrate? They're not interchangeable with each other either.

r/pharmacy659y ago

Fenofibrate and Zetia

Has anyone seen this combination used in the retail setting? The Zetia package insert states these can be used in combination, but I was just wondering how that translates to real life.

r/pharmacy3912y ago

How to use FDA orange book?

r/pharmacy2410y ago

Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.

Community Discussions

No community discussions found for PITAVASTATIN yet.

FENOFIBRATE vs PITAVASTATIN: What You Should Know

Key Differences

FENOFIBRATE is a Fibrate, while PITAVASTATIN belongs to the Other class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.